Susquehanna International Group’s Jade Biosciences JBIO Stock Holding History

Susquehanna International Group’s Portfolio JBIO Stock Details JBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$809K	Sell	57,600 -16,800	-23%	-$243K	﹤0.01%	8448
2025 Q4	$1.15M	Buy	74,400 +17,100	+30%	+$201K	﹤0.01%	6876
2025 Q3	$494K	Sell	57,300 -1,000	-2%	-$8.17K	﹤0.01%	8976
2025 Q2	$582K	Buy	58,300 +56,777	+3,728%	+$1.93M	﹤0.01%	8818
2025 Q1	$134K	Buy	1,523 +17	+1%	+$1.49K	﹤0.01%	11310
2024 Q4	$140K	Buy	1,506 +772	+105%	+$66.5K	﹤0.01%	11075
2024 Q3	$53.7K	Sell	734 -469	-39%	-$30.3K	﹤0.01%	11357
2024 Q2	$69.9K	Buy	+1,203	New	+$798K	﹤0.01%	11246

Other funds holding JBIO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Susquehanna International Group's JBIO Position: Q1 2026 in Review

Susquehanna International Group opened a new position in Jade Biosciences (JBIO) in Q1 2026: 18,308 shares worth $257K. The stake represents ﹤0.01% of the portfolio and ranks #11207 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in JBIO as recently as Q3 2025.

Susquehanna International Group first reported a position in JBIO in Q4 2021 and has held it in 7 quarters since. The position peaked at $392K in Q2 2025. 120 funds tracked by Wall St. Rank hold JBIO as of Q1 2026.

Susquehanna International Group held 18,308 shares of Jade Biosciences worth $257K as of Q1 2026.
Jade Biosciences was a new Susquehanna International Group position in Q1 2026.
Jade Biosciences made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #11207 holding.
Susquehanna International Group first reported a position in Jade Biosciences in Q4 2021 and has held it in 7 quarters since.
Susquehanna International Group's Jade Biosciences position peaked at $392K in Q2 2025.
120 funds tracked by Wall St. Rank held Jade Biosciences as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.